Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AMG-355 by Amgen for Metastatic Colorectal Cancer: Likelihood of Approval
AMG-355 is under clinical development by Amgen and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
AMG-355 by Amgen for Non-Small Cell Lung Cancer: Likelihood of Approval
AMG-355 is under clinical development by Amgen and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
AMG-355 by Amgen for Solid Tumor: Likelihood of Approval
AMG-355 is under clinical development by Amgen and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
AMG-355 by Amgen for Gastric Cancer: Likelihood of Approval
AMG-355 is under clinical development by Amgen and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...